GSK (GSK) Stock Forecast & Price Target

→ This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad)

GBX 1,608.03

-3.97 (-0.25%)

(As of 05:53 AM ET)

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines Insider Trades Sustainability

GSK - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 7 Analyst Ratings

Consensus Price Target

GBX 1,675.63

High Forecast	GBX 1,950
Average Forecast	GBX 1,675.63
Low Forecast	GBX 1,390

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	GBX 1,675.63	GBX 1,675.63	GBX 1,658.75	GBX 1,573.33

Get GSK Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Ad Weiss Ratings

Radical change coming — do this NOW to protect yourself

I recently uncovered a way the government could use the next crisis as a pretext to gain more control … and radically change life in America as we know it today. And a Draconian set of technologies that could impose a new kind of financial surveillance in America.

Click here to learn more.

GSK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GSK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GSK Stock vs. The Competition

Type	GSK	Medical Companies
Consensus Rating Score	2.29	2.70
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	GBX 1,950	+20.89%
6/18/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Underweight
6/12/2024	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy
5/7/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight	GBX 1,725	-1.96%
2/14/2024	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	GBX 1,650 ➝ GBX 1,820	+9.41%
11/28/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral
Get the Latest News and Ratings for GSK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.
9/25/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		GBX 1,440 ➝ GBX 1,585	+3.39%
7/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		GBX 1,450 ➝ GBX 1,390	+5.22%
6/26/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold	GBX 1,575	+10.78%
3/6/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keyur Parekh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		GBX 2,000	+38.68%
2/2/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dominic Lunn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral	GBX 1,510	+6.16%
2/1/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Leuchten Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		GBX 1,245	-13.73%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:18 AM ET.

GSK Forecast - Frequently Asked Questions

What is GSK's stock forecast and purchase recommendation?: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for GSK is GBX 1,675.63, with a high forecast of GBX 1,950 and a low forecast of GBX 1,390. The consensus rating for GSK stock is Hold based on the current 1 sell rating, 3 hold ratings and 3 buy ratings for GSK. Learn more on GSK's analyst rating history.
Do Wall Street analysts like GSK more than its competitors?: Analysts like GSK less than other "medical" companies. The consensus rating for GSK is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GSK compares to other companies.
Does GSK's stock price have much upside?: According to analysts, GSK's stock has a predicted upside of 6.31% based on their 12-month stock forecasts.